Italian observational study in patients with metastatic colorectal cancer (mCRC) treated with first-line cetuximab based regimen (ObservEr study).Francesca Di Fabio, Carmine Pinto, Ivan Lolli et al.|Journal of Clinical Oncology|2014Cited by 1